Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
Rev. Soc. Bras. Med. Trop
;
53: e20180498, 2020. tab
Article
Dans Anglais
| LILACS
| ID: biblio-1057281
ABSTRACT
Abstract INTRODUCTION:
Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance.METHODS:
Data were obtained from ICUs between 2010 and 2013.RESULTS:
P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidrug resistant. We observed increasing resistance to carbapenems and polymyxin B and growing consumption of aminoglycosides, meropenem, ceftazidime, and polymyxin B. The regression impact between resistance and consumption was significant with respect to amikacin, imipenem, meropenem, and polymyxin B.CONCLUSIONS:
Monitoring antimicrobial consumption and resistant microorganisms should be reinforced to combat antimicrobial- and multi-drug resistance.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Pseudomonas aeruginosa
/
Infections à Pseudomonas
/
Infection croisée
Type d'étude:
Étude de prévalence
/
Facteurs de risque
Limites du sujet:
Humains
langue:
Anglais
Texte intégral:
Rev. Soc. Bras. Med. Trop
Thème du journal:
Médecine tropicale
Année:
2020
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Universidade Federal de São Paulo/BR
/
Universidade Presbiteriana Mackenzie/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS